Reviva Pharmaceuticals Holdings's total assets for Q4 2024 were $15.50M, an increase of 103.19% from the previous quarter. RVPH total liabilities were $14.69M for the fiscal quarter, a -16.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.